This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs

No Significant Event

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

Event Date: 08/03/2020
Location: Virtual
Subject: Listening Session with Canopy Growth
FDA Participant/Group: TYNA DAO; RICHARD MELLON; SUPRATIM CHOUDHURI; LOIS FREED; CASSANDRA TAYLOR; PATRICK COURNOYER; PATRICK CANNON; APRIL ALEXANDROW; LOWELL SCHILLER; SHARON MAYL;
Non FDA Participant/Group: David Culver, Jordan Sinclair, Kelly Fair, Mark Ware, Phil Shaer, Tim Lefever (Canopy Growth);

Event Date: 08/05/2020
Location: Virtual
Subject: National Academies of Sciences, Engineering, and Medicine: Drug Research and Development for Adults Across the Older Age Span Workshop
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, industry, patients, federal government, and other stakeholders

Event Date: 08/06/2020
Location: Virtual
Subject: Reagan-Udall Foundation: COVID-19 Evidence Accelerator Collaborative Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Patient groups, health care providers, industry, academia, and other stakeholders

Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs

No Significant Event

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 08/05/2020
Location: Virtual
Subject: Food Safety and Supply Chain Issues
FDA Participant/Group: Several FDA senior officials and staff
Non FDA Participant/Group: Several executives from the food industry

Official Name: Lowell Schiller, Principal Associate Commissioner for Policy

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: John Wagner, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Acting Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event